ExodusPoint Capital Management LP Grows Position in The Clorox Company (NYSE:CLX)

ExodusPoint Capital Management LP boosted its holdings in The Clorox Company (NYSE:CLXFree Report) by 187.9% during the 4th quarter, HoldingsChannel.com reports. The fund owned 698,900 shares of the company’s stock after buying an additional 456,114 shares during the period. Clorox makes up 0.8% of ExodusPoint Capital Management LP’s investment portfolio, making the stock its 9th largest position. ExodusPoint Capital Management LP’s holdings in Clorox were worth $113,508,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. World Investment Advisors bought a new position in Clorox in the fourth quarter valued at about $324,000. Groupama Asset Managment purchased a new stake in shares of Clorox in the 4th quarter worth $1,939,000. Trexquant Investment LP purchased a new position in Clorox during the fourth quarter valued at $8,054,000. Headlands Technologies LLC lifted its position in Clorox by 61.5% during the fourth quarter. Headlands Technologies LLC now owns 3,156 shares of the company’s stock valued at $513,000 after purchasing an additional 1,202 shares in the last quarter. Finally, Geode Capital Management LLC grew its holdings in Clorox by 2.3% during the fourth quarter. Geode Capital Management LLC now owns 3,098,302 shares of the company’s stock valued at $501,925,000 after purchasing an additional 69,969 shares during the period. 78.53% of the stock is owned by hedge funds and other institutional investors.

Analysts Set New Price Targets

Several research analysts have recently commented on the company. Royal Bank of Canada reaffirmed a “sector perform” rating and issued a $150.00 price objective on shares of Clorox in a research note on Thursday, January 30th. JPMorgan Chase & Co. upped their target price on shares of Clorox from $171.00 to $173.00 and gave the stock a “neutral” rating in a report on Tuesday, February 4th. Evercore ISI raised their price target on Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. Barclays lowered their target price on shares of Clorox from $140.00 to $139.00 and set an “underweight” rating on the stock in a report on Thursday, March 27th. Finally, Wells Fargo & Company cut their price objective on Clorox from $161.00 to $155.00 and set an “equal weight” rating for the company in a research report on Wednesday. Three investment analysts have rated the stock with a sell rating, ten have issued a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the company has a consensus rating of “Hold” and an average target price of $159.00.

Read Our Latest Stock Report on Clorox

Clorox Stock Down 0.1 %

Shares of CLX opened at $147.77 on Thursday. The business has a fifty day moving average of $150.61 and a 200 day moving average of $158.66. The company has a market cap of $18.20 billion, a PE ratio of 40.37, a P/E/G ratio of 2.62 and a beta of 0.45. The company has a quick ratio of 0.60, a current ratio of 0.94 and a debt-to-equity ratio of 20.52. The Clorox Company has a 52-week low of $127.60 and a 52-week high of $171.37.

Clorox (NYSE:CLXGet Free Report) last posted its quarterly earnings data on Monday, February 3rd. The company reported $1.55 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same quarter in the previous year, the company posted $2.16 earnings per share. On average, sell-side analysts expect that The Clorox Company will post 7.15 EPS for the current year.

Clorox Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Friday, May 9th. Investors of record on Wednesday, April 23rd will be paid a $1.22 dividend. This represents a $4.88 annualized dividend and a yield of 3.30%. The ex-dividend date is Wednesday, April 23rd. Clorox’s dividend payout ratio is presently 133.33%.

About Clorox

(Free Report)

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.

Featured Articles

Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLXFree Report).

Institutional Ownership by Quarter for Clorox (NYSE:CLX)

Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.